SCHEMBL711441

SCHEMBL711441

C#Cc1cc(OC)cc(OC)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
CYP1A1 P04798 8/20 0.44
CYP1B1 Q16678 8/20 0.44
CYP1A2 P05177 5/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2E1 P05181 2/20 0.39
CYP2C8 P10632 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2A6 P11509 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP4B1 P13584 2/20 0.39
CYP2B6 P20813 2/20 0.39
CYP3A5 P20815 2/20 0.39
CYP2A7 P20853 2/20 0.39
CYP3A7 P24462 2/20 0.39
CYP2F1 P24903 2/20 0.39
CYP2C18 P33260 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2J2 P51589 2/20 0.39
CYP4F2 P78329 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16735426 0.95 ALDH1A1 (0.50) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
SCHEMBL17552583 0.86 ALDH1A1 (0.42) ALDH1A1CYP1A1CYP1B1CYP3A4PDE2A
SCHEMBL15720878 0.84 ALDH1A1 (0.42) ALDH1A1CYP1A1CYP1B1CYP3A4PDE2A
SCHEMBL7038977 0.84 CYP3A4 (0.45) ALDH1A1CYP1A1CYP1B1CYP3A4ABL1
SCHEMBL712263 0.83 APP (0.52) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
SCHEMBL674040 0.78 ALDH1A1 (0.65) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
SCHEMBL182676 0.77 ACHE (0.50) ALDH1A1CYP3A4CA12CA1CA2
SCHEMBL29666208 0.77 ACHE (0.50) ALDH1A1CYP3A4CA12CA1CA2
1,3,5-Trimethoxybenzene SCHEMBL28493 0.76 ALDH1A1 (1.00) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4
SCHEMBL11475256 0.76 ALDH1A1 (0.61) ALDH1A1CYP1A1CYP1B1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118638088-B Preparation method for synthesizing flavonoid compounds based on carbon dioxide and alkyne 湖南工程学院 2024-11-22 CN claimed
CN-115369429-B Selective borohydride reaction method for electrochemically catalyzing alkyne 南京林业大学 2024-11-08 CN claimed
CN-118515716-A NNN-pyridine-quinoline cobalt complex, preparation method and catalytic alkyne hydrosilylation reaction 石河子大学 2024-08-20 CN claimed
US-11814462-B2 Functionalized cyclic polymers and methods of preparing same UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2023-11-14 US claimed
CN-113845481-B Synthesis method of 4, 4-dimethyl-4, 5-dihydropyridazin-3-one 泉州师范学院 2023-05-30 CN claimed
CN-115785103-A Synthetic method of medicine fubatinib for treating bile duct cancer 北京康立生医药技术开发有限公司 2023-03-14 CN claimed
CN-115369429-A Selective hydroboration reaction method for catalyzing alkyne through electrochemistry 南京林业大学 2022-11-22 CN claimed
CN-114874088-A Acetylenic acid and preparation method thereof 中国科学院上海高等研究院 2022-08-09 CN claimed
US-20220056167-A1 Functionalized Cyclic Polymers and Methods of Preparing Same NATIONAL SCIENCE FOUNDATION 2022-02-24 US claimed
CN-113845481-A Synthesis method of 4, 4-dimethyl-4, 5-dihydropyridazin-3-one 泉州师范学院 2021-12-28 CN claimed
WO-2020223672-A1 FUNCTIONALIZED CYCLIC POLYMERS AND METHODS OF PREPARING SAME UNIVERSITY OF FLORIDA RESEARCHFOUNDATION, INC. (US) 2020-11-05 WO claimed
CN-106831584-B A kind of efficient method for preparing tri- substituted pyrazolecarboxylic class compound of 1,3,5- 江西师范大学 2019-11-22 CN claimed
US-10441948-B2 Ruthenium-or osmium-based complex catalysts ARLANXEO DEUTSCHLAND GMBH (DE) 2019-10-15 US claimed
EP-3283496-B1 RUTHENIUM- OR OSMIUM-BASED COMPLEX CATALYSTS ARLANXEO DEUTSCHLAND GMBH (DE) 2019-06-19 EP claimed
US-20180290134-A1 RUTHENIUM-OR OSMIUM-BASED COMPLEX CATALYSTS ARLANXEO DEUTSCHLAND GMBH (DE) 2018-10-11 US claimed
EP-3283496-A1 RUTHENIUM- OR OSMIUM-BASED COMPLEX CATALYSTS ARLANXEO Deutschland GmbH (DE) 2018-02-21 EP claimed
WO-2016166097-A1 RUTHENIUM- OR OSMIUM-BASED COMPLEX CATALYSTS ARLANXEO DEUTSCHLAND GMBH (DE) 2016-10-20 WO claimed
EP-3081572-A1 RUTHENIUM-OR OSMIUM-BASED COMPLEX CATALYSTS ARLANXEO Deutschland GmbH (DE) 2016-10-19 EP claimed
CN-104496770-A Method for producing acetophenone compound employing arylethynylene hydration reaction UNIV HUNAN 2015-04-08 CN claimed
EP-1244617-B1 SUBSTITUTED AMINOALKYLAMIDE DERIVATIVES AS ANTAGONISTS OF FOLLICLE STIMULATING HORMONE ORTHO MCNEIL PHARM INC (US) 2005-02-16 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10441948-B2 Ruthenium-or osmium-based complex catalysts OSTC, OSBP, OSBPL3 ALDH1A1 1283/4885CYP1A1 2320/4885CYP1B1 3238/4885
US-20180290134-A1 RUTHENIUM-OR OSMIUM-BASED COMPLEX CATALYSTS OSTC, OSBP, OSBPL3 ALDH1A1 1283/4885CYP1A1 2320/4885CYP1B1 3238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.